AAPL332.16+1.84 (+0.56%) ▲|ABBV260.78+0.85 (+0.33%) ▲|ABT96.81+0.12 (+0.12%) ▲|ACN202.41-9.89 (-4.66%) ▼|ADBE237.15-4.13 (-1.71%) ▼|AMAT543.08+13.78 (+2.60%) ▲|AMD633.65+17.92 (+2.91%) ▲|AMGN403.55-3.73 (-0.91%) ▼|AMT160.93-0.13 (-0.08%) ▼|AMZN250.23+2.00 (+0.80%) ▲|AVGO354.86+11.22 (+3.27%) ▲|AXP301.93-0.16 (-0.05%) ▼|BA192.63+0.35 (+0.18%) ▲|BAC53.49-0.25 (-0.46%) ▼|BKNG158.81-1.48 (-0.92%) ▼|BLK1,066.22+1.86 (+0.17%) ▲|BMY60.69-0.14 (-0.23%) ▼|BNY144.49+0.57 (+0.40%) ▲|BRK-B501.04+0.54 (+0.11%) ▲|C127.54+0.54 (+0.43%) ▲|CAT846.10+19.75 (+2.39%) ▲|CL84.09-0.44 (-0.52%) ▼|CMCSA21.54-0.16 (-0.74%) ▼|COF194.88+0.40 (+0.21%) ▲|COP126.75-0.31 (-0.24%) ▼|COST912.60-2.35 (-0.26%) ▼|CRM234.35-2.34 (-0.99%) ▼|CSCO111.31+2.97 (+2.74%) ▲|CVS86.78+1.58 (+1.85%) ▲|CVX206.66-0.44 (-0.21%) ▼|DE676.74+9.48 (+1.42%) ▲|DHR215.55+3.79 (+1.79%) ▲|DIS102.14+0.81 (+0.80%) ▲|DUK113.94+0.20 (+0.18%) ▲|EMR161.88+3.31 (+2.08%) ▲|FDX289.43+2.36 (+0.82%) ▲|GD329.09-3.63 (-1.09%) ▼|GE311.79-0.61 (-0.19%) ▼|GEV988.27+0.82 (+0.08%) ▲|GILD144.76-2.75 (-1.86%) ▼|GM78.43-0.88 (-1.11%) ▼|GOOG338.66+3.73 (+1.11%) ▲|GOOGL341.85+3.61 (+1.07%) ▲|GS901.00+4.33 (+0.48%) ▲|HD283.42+0.96 (+0.34%) ▲|HON214.95+1.15 (+0.54%) ▲|IBM222.40-3.22 (-1.43%) ▼|INTC122.73+2.73 (+2.28%) ▲|INTU279.65-3.13 (-1.11%) ▼|ISRG397.61-3.63 (-0.90%) ▼|JNJ256.71-1.96 (-0.76%) ▼|JPM331.02-2.16 (-0.65%) ▼|KO85.37-0.74 (-0.85%) ▼|LIN481.31+11.86 (+2.53%) ▲|LLY1,140.69-9.17 (-0.80%) ▼|LMT504.03-1.48 (-0.29%) ▼|LOW181.67-0.72 (-0.39%) ▼|LRCX350.73+10.63 (+3.12%) ▲|MA550.64+0.64 (+0.12%) ▲|MCD231.65-0.19 (-0.08%) ▼|MDLZ57.97+0.21 (+0.35%) ▲|MDT87.41+0.97 (+1.12%) ▲|META728.94+3.01 (+0.41%) ▲|MMM162.99-0.03 (-0.02%) ▼|MO67.09+0.14 (+0.21%) ▲|MRK143.57-0.24 (-0.17%) ▼|MS189.44+1.43 (+0.76%) ▲|MSFT514.04+1.24 (+0.24%) ▲|MU1,080.84-16.55 (-1.51%) ▼|NEE77.06+0.71 (+0.92%) ▲|NFLX66.83-1.03 (-1.51%) ▼|NKE33.19-1.96 (-5.58%) ▼|NOW135.16-2.61 (-1.89%) ▼|NVDA235.53+4.67 (+2.02%) ▲|ORCL141.08+3.01 (+2.18%) ▲|PEP125.34-0.26 (-0.21%) ▼|PFE27.64-0.49 (-1.72%) ▼|PG144.10+0.15 (+0.11%) ▲|PLTR189.27-0.77 (-0.40%) ▼|PM187.17+0.59 (+0.32%) ▲|QCOM186.73+4.64 (+2.55%) ▲|RTX185.37+0.36 (+0.19%) ▲|SBUX94.86-0.02 (-0.02%) ▼|SCHW96.54-1.83 (-1.86%) ▼|SO83.78+0.31 (+0.37%) ▲|SPG201.69+0.88 (+0.44%) ▲|T24.26-0.05 (-0.19%) ▼|TMO653.90+1.39 (+0.21%) ▲|TMUS163.15+1.42 (+0.88%) ▲|TSLA372.11+18.00 (+5.08%) ▲|TXN296.11+14.80 (+5.26%) ▲|UBER67.61-0.27 (-0.40%) ▼|UNH367.44+2.24 (+0.61%) ▲|UNP277.52+5.10 (+1.87%) ▲|UPS93.90+0.01 (+0.01%) ▲|USB57.47+0.11 (+0.19%) ▲|V359.58-0.27 (-0.08%) ▼|VZ45.94-0.05 (-0.10%) ▼|WFC80.15-0.10 (-0.12%) ▼|WMT104.12-0.15 (-0.14%) ▼|XOM163.84+0.02 (+0.01%) ▲|AAPL332.16+1.84 (+0.56%) ▲|ABBV260.78+0.85 (+0.33%) ▲|ABT96.81+0.12 (+0.12%) ▲|ACN202.41-9.89 (-4.66%) ▼|ADBE237.15-4.13 (-1.71%) ▼|AMAT543.08+13.78 (+2.60%) ▲|AMD633.65+17.92 (+2.91%) ▲|AMGN403.55-3.73 (-0.91%) ▼|AMT160.93-0.13 (-0.08%) ▼|AMZN250.23+2.00 (+0.80%) ▲|AVGO354.86+11.22 (+3.27%) ▲|AXP301.93-0.16 (-0.05%) ▼|BA192.63+0.35 (+0.18%) ▲|BAC53.49-0.25 (-0.46%) ▼|BKNG158.81-1.48 (-0.92%) ▼|BLK1,066.22+1.86 (+0.17%) ▲|BMY60.69-0.14 (-0.23%) ▼|BNY144.49+0.57 (+0.40%) ▲|BRK-B501.04+0.54 (+0.11%) ▲|C127.54+0.54 (+0.43%) ▲|CAT846.10+19.75 (+2.39%) ▲|CL84.09-0.44 (-0.52%) ▼|CMCSA21.54-0.16 (-0.74%) ▼|COF194.88+0.40 (+0.21%) ▲|COP126.75-0.31 (-0.24%) ▼|COST912.60-2.35 (-0.26%) ▼|CRM234.35-2.34 (-0.99%) ▼|CSCO111.31+2.97 (+2.74%) ▲|CVS86.78+1.58 (+1.85%) ▲|CVX206.66-0.44 (-0.21%) ▼|DE676.74+9.48 (+1.42%) ▲|DHR215.55+3.79 (+1.79%) ▲|DIS102.14+0.81 (+0.80%) ▲|DUK113.94+0.20 (+0.18%) ▲|EMR161.88+3.31 (+2.08%) ▲|FDX289.43+2.36 (+0.82%) ▲|GD329.09-3.63 (-1.09%) ▼|GE311.79-0.61 (-0.19%) ▼|GEV988.27+0.82 (+0.08%) ▲|GILD144.76-2.75 (-1.86%) ▼|GM78.43-0.88 (-1.11%) ▼|GOOG338.66+3.73 (+1.11%) ▲|GOOGL341.85+3.61 (+1.07%) ▲|GS901.00+4.33 (+0.48%) ▲|HD283.42+0.96 (+0.34%) ▲|HON214.95+1.15 (+0.54%) ▲|IBM222.40-3.22 (-1.43%) ▼|INTC122.73+2.73 (+2.28%) ▲|INTU279.65-3.13 (-1.11%) ▼|ISRG397.61-3.63 (-0.90%) ▼|JNJ256.71-1.96 (-0.76%) ▼|JPM331.02-2.16 (-0.65%) ▼|KO85.37-0.74 (-0.85%) ▼|LIN481.31+11.86 (+2.53%) ▲|LLY1,140.69-9.17 (-0.80%) ▼|LMT504.03-1.48 (-0.29%) ▼|LOW181.67-0.72 (-0.39%) ▼|LRCX350.73+10.63 (+3.12%) ▲|MA550.64+0.64 (+0.12%) ▲|MCD231.65-0.19 (-0.08%) ▼|MDLZ57.97+0.21 (+0.35%) ▲|MDT87.41+0.97 (+1.12%) ▲|META728.94+3.01 (+0.41%) ▲|MMM162.99-0.03 (-0.02%) ▼|MO67.09+0.14 (+0.21%) ▲|MRK143.57-0.24 (-0.17%) ▼|MS189.44+1.43 (+0.76%) ▲|MSFT514.04+1.24 (+0.24%) ▲|MU1,080.84-16.55 (-1.51%) ▼|NEE77.06+0.71 (+0.92%) ▲|NFLX66.83-1.03 (-1.51%) ▼|NKE33.19-1.96 (-5.58%) ▼|NOW135.16-2.61 (-1.89%) ▼|NVDA235.53+4.67 (+2.02%) ▲|ORCL141.08+3.01 (+2.18%) ▲|PEP125.34-0.26 (-0.21%) ▼|PFE27.64-0.49 (-1.72%) ▼|PG144.10+0.15 (+0.11%) ▲|PLTR189.27-0.77 (-0.40%) ▼|PM187.17+0.59 (+0.32%) ▲|QCOM186.73+4.64 (+2.55%) ▲|RTX185.37+0.36 (+0.19%) ▲|SBUX94.86-0.02 (-0.02%) ▼|SCHW96.54-1.83 (-1.86%) ▼|SO83.78+0.31 (+0.37%) ▲|SPG201.69+0.88 (+0.44%) ▲|T24.26-0.05 (-0.19%) ▼|TMO653.90+1.39 (+0.21%) ▲|TMUS163.15+1.42 (+0.88%) ▲|TSLA372.11+18.00 (+5.08%) ▲|TXN296.11+14.80 (+5.26%) ▲|UBER67.61-0.27 (-0.40%) ▼|UNH367.44+2.24 (+0.61%) ▲|UNP277.52+5.10 (+1.87%) ▲|UPS93.90+0.01 (+0.01%) ▲|USB57.47+0.11 (+0.19%) ▲|V359.58-0.27 (-0.08%) ▼|VZ45.94-0.05 (-0.10%) ▼|WFC80.15-0.10 (-0.12%) ▼|WMT104.12-0.15 (-0.14%) ▼|XOM163.84+0.02 (+0.01%) ▲|
26.4 C
New York
Friday, October 2, 2026

Tag: information

Bound’s Publishing Course is building the next generation of creative professionals

MUMBAI, India, July 3, 2025 /PRNewswire/ -- Bound, India's leading creative education platform, announces the next edition of The Bound Publishing Course, a first-of-its-kind,...

EQT to acquire Europa Biosite, a distributor of life science products

EQT Healthcare Growth to acquire Europa Biosite, a distributor of over ten million high-quality life science reagents to academic and biopharma researchers across Europe...

CJ Foods’ Cuisine. K Young Chefs Complete Korean Cooking Classes Across Three European Countries

-  Young chefs from CJ's Cuisine. K bring Korean culinary culture to Europe through hands-on cooking classes in London, Berlin, and Madrid SEOUL, South Korea,...

Essential Pharma appoints experienced pharmaceutical leaders Simon Ramsden and Rob Smith to leadership team

Essential Pharma appoints experienced pharmaceutical leaders Simon Ramsden and Rob Smith to leadership team

Oxford BioTherapeutics Announces Third Oncology Drug Candidate from Boehringer Ingelheim Collaboration Selected to Advance into IND-Enabling Studies

Drug candidate is one of several oncology assets approaching or in clinical development, discovered through Oxford BioTherapeutics’ proprietary OGAP®-Verify discovery platform

One of Finland’s largest energy storage facilities commissioned in Lappeenranta – Merus Power’s EUR 15 million delivery completed

TAMPERE, Finland, July 03, 2025 (GLOBE NEWSWIRE) -- The energy storage facility delivered by Merus Power to Lappeenranta, Finland, has been completed and put into market use on 15 May 2025. The energy storage facility is owned by a joint venture between Ardian’s Clean Energy Evergreen Fund and the local energy provider Lappeenrannan Energia. It is one of the largest energy storage facilities in use on the Finnish electricity market with an output of approximately 38 megawatts and energy of 43 megawatt hours. The completion of the project is significant for Merus Power, as it is the largest energy storage facility manufactured by the company.

Invitation to the Volvo Group report on the second quarter 2025

GOTHENBURG, Sweden, July 3, 2025 /PRNewswire/ -- The Volvo Group report for the second quarter 2025 will be published on July 17, at 7.20...

Renewable energy market set for major boost as SKF announces tidal stream breakthrough

GOTHENBURG, Sweden, July 3, 2025 /PRNewswire/ -- SKF has joined forces with Proteus Marine Renewables to deliver cutting-edge technology for MeyGen. Operated by SAE Renewables,...

Transaction in Own Shares

LEI: 213800NNT42FFIZB1T09 
3 July 2025

Transaction in Own Shares

Transaction in Own Shares

Annual report 2024/25: Bang & Olufsen reports a year of transition, achieving record-high gross margin, positive operating profit, and strengthened branded channel performance

Bang & Olufsen ended the year with 4% revenue growth in Q4 and a 1% decline in local currencies for the full year, bringing total revenue to DKK 2.6bn. The gross margin continued to increase, reaching a record-high 55.8% in Q4, and 55.0% at year end. For the full year, the EBIT margin before special items was 1.0%, and free cash flow amounted to DKK 16m. Overall, the results were in line with plans and aligned with the outlook for the year.

Nixol Weight Loss Capsules UK & IE Officially Launched- Exploring the Science Behind its Weight Loss Tablets Promises

New York City, NY, July 03, 2025 (GLOBE NEWSWIRE) -- In 2025, Nixol, a plant-based dietary supplement, made its debut in the United Kingdom and Ireland, marking a significant entry into the wellness supplement market. Designed to support healthy weight management, boost metabolism, and curb cravings, Nixol has positioned itself as a natural, vegan-friendly alternative to traditional weight loss solutions. Unlike products that rely on synthetic stimulants or restrictive diets, Nixol leverages a blend of carefully selected, science-backed ingredients to promote sustainable fat reduction and overall well-being. This article provides an in-depth exploration of Nixol’s launch, its formulation, claims, scientific backing, customer feedback, and the broader context of its market entry, while critically examining its potential effectiveness and limitations. Visit Official Website 

Novotech Earns Frost & Sullivan’s 2025 Global Company of the Year Recognition for Excellence in Biotech Clinical Research Services

Recognized for its biotech-first focus, innovation in clinical trial delivery, and best-in-class client experience, Novotech sets the global standard in contract research for biotechs...

Novotech Earns Frost & Sullivan’s 2025 Global Company of the Year Recognition for Excellence in Biotech Clinical Research Services

Recognized for its biotech-first focus, innovation in clinical trial delivery, and best-in-class client experience, Novotech sets the global standard in contract research for biotechs...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsInformation